A Korean multi-center, real-world, retrospective study of first-line pazopanib in unselected patients with metastatic renal clear-cell carcinoma

類似資料

• A Korean single-center, real-world, retrospective study of first-line weekly paclitaxel in patients with metastatic angiosarcoma
  著者:: Byeon, Seonggyu, 等
  出版事項: (2016)
• Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study
  著者:: Jung, Ki Sun, 等
  出版事項: (2018)
• Pazopanib monotherapy in the treatment of pretreated, metastatic uterine sarcoma: a single-center retrospective study
  著者:: Kim, Hyun-Jun, 等
  出版事項: (2018)
• Successful use of pazopanib for treatment of refractory metastatic hemangiopericytoma
  著者:: Lee, Su Jin, 等
  出版事項: (2014)
• Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib
  著者:: Kim, Myung Soo, 等
  出版事項: (2018)